Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Total Current Liabilities (2023 - 2025)

Upstream Bio (UPB) has 3 years of Total Current Liabilities data on record, last reported at $11.9 million in Q3 2025.

  • For Q3 2025, Total Current Liabilities rose 9.51% year-over-year to $11.9 million; the TTM value through Sep 2025 reached $11.9 million, up 9.51%, while the annual FY2024 figure was $10.7 million, 64.8% up from the prior year.
  • Total Current Liabilities reached $11.9 million in Q3 2025 per UPB's latest filing, up from $10.9 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $11.9 million in Q3 2025 and bottomed at $6.5 million in Q4 2023.
  • Average Total Current Liabilities over 3 years is $10.1 million, with a median of $10.8 million recorded in 2024.
  • Peak YoY movement for Total Current Liabilities: surged 64.8% in 2024, then grew 9.51% in 2025.
  • A 3-year view of Total Current Liabilities shows it stood at $6.5 million in 2023, then soared by 64.8% to $10.7 million in 2024, then increased by 10.91% to $11.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $11.9 million in Q3 2025, $10.9 million in Q2 2025, and $9.6 million in Q1 2025.